Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Maj

Showing results (161-170 of 226) with videos related to

Pageof 23
Sort By:
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|July 15, 1988
[Granular cell myoblastoma of the pharynx]J Maj, M Wieczorek, A Wolak, et al.
Polish Journal of Pharmacology and Pharmacy|October 1, 1975
Central D-fenfluramine actionE Mogilnicka, J Maj, L Pawlowski, et al.
Neuroscience Letters|January 1, 1990
The effect of repeated treatment with brofaromine, moclobemide and deprenyl on alpha 1-adrenergic and dopaminergic receptors in the rat brainV Klimek, G Nowak, J Zak, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Roxindole, a potential antidepressant. I. Effect on the dopamine systemJ Maj, K Kolodziejczyk, Z Rogóz, et al.
Journal of Neural Transmission|January 1, 1987
Pharmacological properties of EXP 561, a potential antidepressant drugJ Maj, G Skuza, H Sowińska, et al.
Pharmacopsychiatry|March 1, 1997
Roxindole, a dopamine autoreceptor agonist with a potential antidepressant activity. II. Effects on the 5-hydroxytryptamine systemJ Maj, K Kołodziejczyk, Z Rogóz, et al.
Journal of Neural Transmission|January 1, 1982
Different pharmacokinetic and pharmacological effects following acute and chronic treatment with imipramineJ Maj, M Melzacka, E Mogilnicka, et al.
Psychopharmacology|January 1, 1981
Chronic treatment with some atypical antidepressants increases the brain level of 3-methoxy-4-hydroxyphenylglycol (MHPG) in ratsE Przegaliński, A Kordecka-Magiera, E Mogilnicka, et al.
Polish Journal of Pharmacology and Pharmacy|July 1, 1985
Central antiserotonin action of fluperlapineJ Maj, E Chojnacka-Wójcik, A Lewandowska, et al.
Polish Journal of Pharmacology and Pharmacy|January 1, 1989
The central action of 1-(2-pyrimidinyl)-piperazine, an ipsapirone metaboliteE Tatarczyńska, L Pawłowski, E Chojnacka-Wójcik, et al.
Pageof 23

Showing results (161-170 of 226) with videos related to

Sort By:
Pageof 23
Wiadomosci Lekarskie (Warsaw, Poland : 1960)|July 15, 1988
[Granular cell myoblastoma of the pharynx]J Maj, M Wieczorek, A Wolak, et al.
Polish Journal of Pharmacology and Pharmacy|October 1, 1975
Central D-fenfluramine actionE Mogilnicka, J Maj, L Pawlowski, et al.
Neuroscience Letters|January 1, 1990
The effect of repeated treatment with brofaromine, moclobemide and deprenyl on alpha 1-adrenergic and dopaminergic receptors in the rat brainV Klimek, G Nowak, J Zak, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|January 1, 1996
Roxindole, a potential antidepressant. I. Effect on the dopamine systemJ Maj, K Kolodziejczyk, Z Rogóz, et al.
Journal of Neural Transmission|January 1, 1987
Pharmacological properties of EXP 561, a potential antidepressant drugJ Maj, G Skuza, H Sowińska, et al.
Pharmacopsychiatry|March 1, 1997
Roxindole, a dopamine autoreceptor agonist with a potential antidepressant activity. II. Effects on the 5-hydroxytryptamine systemJ Maj, K Kołodziejczyk, Z Rogóz, et al.
Journal of Neural Transmission|January 1, 1982
Different pharmacokinetic and pharmacological effects following acute and chronic treatment with imipramineJ Maj, M Melzacka, E Mogilnicka, et al.
Psychopharmacology|January 1, 1981
Chronic treatment with some atypical antidepressants increases the brain level of 3-methoxy-4-hydroxyphenylglycol (MHPG) in ratsE Przegaliński, A Kordecka-Magiera, E Mogilnicka, et al.
Polish Journal of Pharmacology and Pharmacy|July 1, 1985
Central antiserotonin action of fluperlapineJ Maj, E Chojnacka-Wójcik, A Lewandowska, et al.
Polish Journal of Pharmacology and Pharmacy|January 1, 1989
The central action of 1-(2-pyrimidinyl)-piperazine, an ipsapirone metaboliteE Tatarczyńska, L Pawłowski, E Chojnacka-Wójcik, et al.
Pageof 23